Sangamo Biosciences (SGMO) Announces Presentation of New ZFP Therapeutic Program Data at ASGCT
Tweet Send to a Friend
Sangamo Biosciences (NASDAQ: SGMO) announced that new data from the company's proprietary ZFP Therapeutic programs in disease models of lysosomal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
